CA2731404A1 - Membranes de polymere bloc permettant d'attenuer un tissu cicatriciel - Google Patents

Membranes de polymere bloc permettant d'attenuer un tissu cicatriciel Download PDF

Info

Publication number: CA2731404A1
Authority: CA; Canada
Prior art keywords: resorbable; base material; tissue; polymer base; membrane
Prior art date: 2008-06-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2731404A

Other languages

English (en)

Inventor

Joerg Tessmar

Thomas Reintjes

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MAST Biosurgery AG

Original Assignee

MAST Biosurgery AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-08

Filing date

2009-06-08

Publication date

2010-01-07

2009-06-08 Application filed by MAST Biosurgery AG filed Critical MAST Biosurgery AG

2010-01-07 Publication of CA2731404A1 publication Critical patent/CA2731404A1/fr

Status Abandoned legal-status Critical Current

Links

231100000241 scar Toxicity 0.000 title claims description 10
229920005597 polymer membrane Polymers 0.000 title description 3
239000012528 membrane Substances 0.000 claims abstract description 140
229920000642 polymer Polymers 0.000 claims abstract description 61
239000000463 material Substances 0.000 claims description 66
229920001223 polyethylene glycol Polymers 0.000 claims description 59
239000002202 Polyethylene glycol Substances 0.000 claims description 46
230000009467 reduction Effects 0.000 claims description 44
239000002356 single layer Substances 0.000 claims description 34
239000000203 mixture Substances 0.000 claims description 23
229920001577 copolymer Polymers 0.000 claims description 20
229920001400 block copolymer Polymers 0.000 claims description 16
239000010410 layer Substances 0.000 claims description 15
230000002209 hydrophobic effect Effects 0.000 claims description 13
230000004888 barrier function Effects 0.000 claims description 12
230000015572 biosynthetic process Effects 0.000 claims description 12
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 12
238000001356 surgical procedure Methods 0.000 claims description 12
239000000126 substance Substances 0.000 claims description 11
229920000428 triblock copolymer Polymers 0.000 claims description 10
239000007943 implant Substances 0.000 claims description 9
230000035876 healing Effects 0.000 claims description 8
239000012530 fluid Substances 0.000 claims description 5
238000004806 packaging method and process Methods 0.000 claims description 5
230000012292 cell migration Effects 0.000 claims description 4
239000003102 growth factor Substances 0.000 claims description 4
230000024245 cell differentiation Effects 0.000 claims description 2
230000004663 cell proliferation Effects 0.000 claims description 2
230000003399 chemotactic effect Effects 0.000 claims description 2
230000002401 inhibitory effect Effects 0.000 claims description 2
230000002297 mitogenic effect Effects 0.000 claims description 2
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 11
206010039580 Scar Diseases 0.000 claims 2
238000001727 in vivo Methods 0.000 claims 2
206010029113 Neovascularisation Diseases 0.000 claims 1
229920000747 poly(lactic acid) Polymers 0.000 abstract description 50
238000000034 method Methods 0.000 abstract description 31
238000002513 implantation Methods 0.000 abstract description 8
210000004379 membrane Anatomy 0.000 description 63
210000001519 tissue Anatomy 0.000 description 37
230000008439 repair process Effects 0.000 description 19
238000001125 extrusion Methods 0.000 description 13
206010019909 Hernia Diseases 0.000 description 10
230000007547 defect Effects 0.000 description 10
210000003195 fascia Anatomy 0.000 description 10
210000004872 soft tissue Anatomy 0.000 description 9
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 8
-1 polytetrafluoroethylene Polymers 0.000 description 8
229920001553 poly(ethylene glycol)-block-polylactide methyl ether Polymers 0.000 description 7
230000037390 scarring Effects 0.000 description 7
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
229920000954 Polyglycolide Polymers 0.000 description 6
239000011148 porous material Substances 0.000 description 6
230000008569 process Effects 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
206010061218 Inflammation Diseases 0.000 description 4
208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 4
208000031737 Tissue Adhesions Diseases 0.000 description 4
210000003484 anatomy Anatomy 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
210000004303 peritoneum Anatomy 0.000 description 4
238000012545 processing Methods 0.000 description 4
239000000243 solution Substances 0.000 description 4
210000003815 abdominal wall Anatomy 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
238000006065 biodegradation reaction Methods 0.000 description 3
230000003328 fibroblastic effect Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
238000012876 topography Methods 0.000 description 3
210000001835 viscera Anatomy 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000013270 controlled release Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000000593 degrading effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
210000003414 extremity Anatomy 0.000 description 2
238000011049 filling Methods 0.000 description 2
238000009472 formulation Methods 0.000 description 2
230000009477 glass transition Effects 0.000 description 2
238000009499 grossing Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
238000005304 joining Methods 0.000 description 2
238000000465 moulding Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000004003 subcutaneous fat Anatomy 0.000 description 2
206010045458 umbilical hernia Diseases 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 1
208000021970 Abdominal wall defect Diseases 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
206010012713 Diaphragmatic hernia Diseases 0.000 description 1
206010013082 Discomfort Diseases 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
206010015677 Exomphalos Diseases 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
206010016997 Forearm fracture Diseases 0.000 description 1
206010017076 Fracture Diseases 0.000 description 1
208000006442 Gastroschisis Diseases 0.000 description 1
206010021620 Incisional hernias Diseases 0.000 description 1
206010024995 Lumbar hernia Diseases 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
208000000450 Pelvic Pain Diseases 0.000 description 1
229920000432 Polylactide-block-poly(ethylene glycol)-block-polylactide Polymers 0.000 description 1
206010060932 Postoperative adhesion Diseases 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
201000010814 Synostosis Diseases 0.000 description 1
206010045210 Tympanic Membrane Perforation Diseases 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
230000003872 anastomosis Effects 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
230000000181 anti-adherent effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000003028 elevating effect Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
210000004013 groin Anatomy 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
208000000509 infertility Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
231100000535 infertility Toxicity 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000003754 machining Methods 0.000 description 1
238000010297 mechanical methods and process Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000007769 metal material Substances 0.000 description 1
239000000178 monomer Substances 0.000 description 1
210000000492 nasalseptum Anatomy 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
201000003508 omphalocele Diseases 0.000 description 1
230000011164 ossification Effects 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
206010034674 peritonitis Diseases 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
239000003805 procoagulant Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000004080 punching Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000007788 roughening Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000000935 solvent evaporation Methods 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
210000004304 subcutaneous tissue Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
231100000057 systemic toxicity Toxicity 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
210000000779 thoracic wall Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000005532 trapping Effects 0.000 description 1
210000003454 tympanic membrane Anatomy 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
201000001988 urethral stricture Diseases 0.000 description 1
238000003466 welding Methods 0.000 description 1
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

CA2731404A 2008-06-08 2009-06-08 Membranes de polymere bloc permettant d'attenuer un tissu cicatriciel Abandoned CA2731404A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US5979508P	2008-06-08	2008-06-08
US61/059,795		2008-06-08
PCT/IB2009/006229 WO2010001250A2 (fr)	2008-06-08	2009-06-08	Membranes de polymere bloc permettant d’attenuer un tissu cicatriciel

Publications (1)

Publication Number	Publication Date
CA2731404A1 true CA2731404A1 (fr)	2010-01-07

Family

ID=41350718

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2731404A Abandoned CA2731404A1 (fr)	2008-06-08	2009-06-08	Membranes de polymere bloc permettant d'attenuer un tissu cicatriciel

Country Status (8)

Country	Link
EP (1)	EP2303351A2 (fr)
JP (1)	JP2011523878A (fr)
KR (1)	KR101367978B1 (fr)
CN (1)	CN102202701A (fr)
AU (1)	AU2009265277A1 (fr)
CA (1)	CA2731404A1 (fr)
MX (1)	MX2010013521A (fr)
WO (1)	WO2010001250A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011156552A1 (fr) *	2010-06-09	2011-12-15	Mast Biosurgery Ag	Accès chirurgical résistant à l'adhésion, renforcement et prothèse de fermeture
TWI754876B (zh) *	2019-12-31	2022-02-11	財團法人工業技術研究院	含藥多層薄膜與其形成方法
KR20250125302A (ko) *	2024-02-14	2025-08-21	주식회사 나노바이오시스템	고막 재생 패치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5711958A (en) *	1996-07-11	1998-01-27	Life Medical Sciences, Inc.	Methods for reducing or eliminating post-surgical adhesion formation
US6211249B1 (en) *	1997-07-11	2001-04-03	Life Medical Sciences, Inc.	Polyester polyether block copolymers
PT1588675E (pt) *	2000-03-10	2008-02-29	Mast Biosurgery Ag	Micromembranas barreira reabsorvíveis para atenuação de tecido cicatricial durante a cicatrização
CA2419831A1 (fr) *	2002-02-28	2003-08-28	Macropore Biosurgery, Inc.	Methodes de determination de la croissance osseuse
JP2010540003A (ja) *	2007-08-27	2010-12-24	マストバイオサージェリーアクチェンゲゼルシャフト	治癒中の瘢痕組織を減ずるための再吸収性障壁微小膜

2009
- 2009-06-08 CA CA2731404A patent/CA2731404A1/fr not_active Abandoned
- 2009-06-08 EP EP09772911A patent/EP2303351A2/fr not_active Withdrawn
- 2009-06-08 AU AU2009265277A patent/AU2009265277A1/en not_active Abandoned
- 2009-06-08 KR KR1020117000449A patent/KR101367978B1/ko not_active Expired - Fee Related
- 2009-06-08 MX MX2010013521A patent/MX2010013521A/es unknown
- 2009-06-08 CN CN2009801281438A patent/CN102202701A/zh active Pending
- 2009-06-08 WO PCT/IB2009/006229 patent/WO2010001250A2/fr not_active Ceased
- 2009-06-08 JP JP2011513072A patent/JP2011523878A/ja active Pending

Also Published As

Publication number	Publication date
WO2010001250A3 (fr)	2010-08-26
KR20110050617A (ko)	2011-05-16
MX2010013521A (es)	2011-05-30
EP2303351A2 (fr)	2011-04-06
WO2010001250A2 (fr)	2010-01-07
AU2009265277A1 (en)	2010-01-07
KR101367978B1 (ko)	2014-03-06
JP2011523878A (ja)	2011-08-25
CN102202701A (zh)	2011-09-28

Legal Events

Date	Code	Title	Description
2011-01-19	EEER	Examination request
2013-08-05	FZDE	Discontinued	Effective date: 20130610

Publication	Publication Date	Title
US7947300B2 (en)	2011-05-24	Resorbable thin membranes
US20060083767A1 (en)	2006-04-20	Surgical prosthesis having biodegradable and nonbiodegradable regions
AU2005272684A1 (en)	2006-02-23	Surgical prosthesis having biodegradable and nonbiodegradable regions
US20100003306A1 (en)	2010-01-07	Pre-shaped user-formable micro-membrane implants
KR101279723B1 (ko)	2013-06-28	치유 동안 반흔 조직을 감쇠시키기 위한 재흡수가능한 장벽 미세막
US20100310628A1 (en)	2010-12-09	Pre-shaped user-formable micro-membrane implants
US20100034869A1 (en)	2010-02-11	Block-polymer membranes for attenuation of scar tissue
CA2731404A1 (fr)	2010-01-07	Membranes de polymere bloc permettant d'attenuer un tissu cicatriciel
US20090304779A1 (en)	2009-12-10	Micro-membrane implant with cusped opening
AU2008258179B2 (en)	2011-07-21	Resorbable thin membranes
US20100310632A1 (en)	2010-12-09	Micro-membrane implant with cusped opening
US20100266663A1 (en)	2010-10-21	Tissue-treating implantable compositions
US20110274739A1 (en)	2011-11-10	Methods for governing tissue growth
KR101178656B1 (ko)	2012-08-30	재흡수가능한 얇은 멤브레인
HK1088522B (en)	2011-10-14	Resorbable thin membranes
AU2011213792A1 (en)	2011-09-08	Resorbable thin membranes